Filing Details
- Accession Number:
- 0001110803-14-000090
- Form Type:
- 4
- Zero Holdings:
- No
- Publication Time:
- 2014-02-19 19:18:38
- Reporting Period:
- 2014-02-18
- Filing Date:
- 2014-02-19
- Accepted Time:
- 2014-02-19 19:18:38
- SEC Url:
- Form 4 Filing
Issuer
Cik | Name | Symbol | Sector (SIC) | IRS No |
---|---|---|---|---|
1110803 | Illumina Inc | ILMN | Laboratory Analytical Instruments (3826) | 330804655 |
Insiders
Cik | Name | Reported Address | Insider Title | Director | Officer | Large Shareholder | Other |
---|---|---|---|---|---|---|---|
1534166 | Nicholas Naclerio | 5200 Illumina Way San Diego CA 92122 | Sr Vp, Corporate & Venture Dev | No | Yes | No | No |
Reported Non-Derivative Transactions
Sec. Name | Acquisiton - Disposition | Date | Amount | Price | Remaning Holdings | Equity Swap Involved | Form Type | Code | Nature of Ownership | Explanation |
---|---|---|---|---|---|---|---|---|---|---|
Common Stock | Acquisiton | 2014-02-18 | 2,000 | $43.37 | 27,781 | No | 4 | M | Direct | |
Common Stock | Disposition | 2014-02-18 | 395 | $167.52 | 27,386 | No | 4 | S | Direct | |
Common Stock | Disposition | 2014-02-18 | 400 | $168.83 | 26,986 | No | 4 | S | Direct | |
Common Stock | Disposition | 2014-02-18 | 405 | $169.77 | 26,581 | No | 4 | S | Direct | |
Common Stock | Disposition | 2014-02-18 | 500 | $170.95 | 26,081 | No | 4 | S | Direct | |
Common Stock | Disposition | 2014-02-18 | 300 | $172.02 | 25,781 | No | 4 | S | Direct |
Equity Swap Involved | Form Type | Code | Nature of Ownership | Explanation |
---|---|---|---|---|
No | 4 | M | Direct | |
No | 4 | S | Direct | |
No | 4 | S | Direct | |
No | 4 | S | Direct | |
No | 4 | S | Direct | |
No | 4 | S | Direct |
Reported Derivative Transactions
Sec. Name | Sec. Type | Acquisiton - Disposition | Date | Amount | Price | Amount - 2 | Price - 2 |
---|---|---|---|---|---|---|---|
Common Stock | Non-Qualified Stock Option (right to buy) | Disposition | 2014-02-18 | 2,000 | $0.00 | 2,000 | $43.37 |
Remaning Holdings | Exercise Date | Expiration Date | Equity Swap Involved | Transaction Form Type | Transaction Code | Nature of Ownership |
---|---|---|---|---|---|---|
80,000 | 2011-08-08 | 2020-06-29 | No | 4 | M | Direct |
Footnotes
- The sale was made pursuant to a 10b5-1 plan.
- Weighted average sale price representing 395 shares sold ranging from $167.01 to $167.81 per share. Number of shares sold at each separate price will be made available to the SEC staff, the issuer, or a security holder of the issuer upon request.
- Weighted average sale price representing 400 shares sold ranging from $168.31 to $169.29 per share. Number of shares sold at each separate price will be made available to the SEC staff, the issuer, or a security holder of the issuer upon request.
- Weighted average sale price representing 405 shares sold ranging from $169.33 to $169.94 per share. Number of shares sold at each separate price will be made available to the SEC staff, the issuer, or a security holder of the issuer upon request.
- Weighted average sale price representing 500 shares sold ranging from $170.57 to $171.39 per share. Number of shares sold at each separate price will be made available to the SEC staff, the issuer, or a security holder of the issuer upon request.
- Weighted average sale price representing 300 shares sold ranging from $171.74 to $172.49 per share. Number of shares sold at each separate price will be made available to the SEC staff, the issuer, or a security holder of the issuer upon request.